Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000878088-10-000021
Filing Date
2010-03-03
Accepted
2010-03-03 18:06:04
Documents
1
Period of Report
2010-03-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 29314
  Complete submission text file 0000878088-10-000021.txt   31215
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Issuer) CIK: 0000878088 (see all company filings)

EIN.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PAR PHARMACEUTICAL COMPANIES, INC. 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address
Campanelli Paul (Reporting) CIK: 0001392459 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10827 | Film No.: 10654733